Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2010-09-14 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2010
Director's Dealing Classification · 99% confidence The document is dated September 14, 2010, and explicitly states it is published according to the Danish Securities Trading Act (§ 28a). The core content is a table detailing transactions (purchase/sale of shares following option exercise) made by a senior executive (CEO, Steen Risgaard). This type of mandatory disclosure regarding personal share transactions by directors and executives is classified as Director's Dealing. The document is short and appears to be a formal regulatory announcement, not a comprehensive report.
2010-09-14 English
Director's Dealing 2010
Director's Dealing Classification · 99% confidence The document explicitly details 'TRADING BY MANAGEMENT' involving an EVP & CFO exercising options to purchase shares. It specifies the transaction date, volume, and value, and cites compliance with the Danish Securities Trading Act. This content directly corresponds to the definition of reporting personal share transactions by company directors and executives, which maps to the 'Director's Dealing' category.
2010-09-13 English
Regulatory Filings 2010
Regulatory Filings
2010-09-13 Danish
Interim / Quarterly Report 2010
Interim / Quarterly Report
2010-08-12 Danish
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (1H) of 2010, detailing sales, EBIT, net profit, cash flow, and balance sheet data. It includes detailed tables comparing 1H 2010 results to 1H 2009 and provides management's analysis of business segments and geographical performance. As it contains substantive financial statements and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2010
2010-08-12 English
Regulatory Filings 2010
Regulatory Filings
2010-03-04 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.